TG468: a text graph convolutional network for predicting clinical response to immune checkpoint inhibitor therapy
K Wang, J Shi, X Tong, N Qu, X Kong… - Briefings in …, 2024 - academic.oup.com
Enhancing cancer treatment efficacy remains a significant challenge in human health.
Immunotherapy has witnessed considerable success in recent years as a treatment for …
Immunotherapy has witnessed considerable success in recent years as a treatment for …
[PDF][PDF] TG468: a text graph convolutional network for predicting clinical response to immune checkpoint inhibitor therapy
K Wang, J Shi, X Tong, N Qu, X Kong… - Briefings in …, 2024 - academic.oup.com
Enhancing cancer treatment efficacy remains a significant challenge in human health.
Immunotherapy has witnessed considerable success in recent years as a treatment for …
Immunotherapy has witnessed considerable success in recent years as a treatment for …
TG468: A Text Graph Convolutional Network for Predicting Clinical Response to Immune Checkpoint Inhibitor Therapy
K Wang, J Shi, X Tong, N Qu, X Kong, S Ni, J Xing, X Li… - medRxiv, 2023 - medrxiv.org
Immunotherapy has achieved significant success in tumor treatment. However, due to
disease heterogeneity, only a fraction of patients respond well to immune checkpoint …
disease heterogeneity, only a fraction of patients respond well to immune checkpoint …
TG468: a text graph convolutional network for predicting clinical response to immune checkpoint inhibitor therapy
K Wang, J Shi, X Tong, N Qu, X Kong… - Briefings in …, 2024 - pubmed.ncbi.nlm.nih.gov
Enhancing cancer treatment efficacy remains a significant challenge in human health.
Immunotherapy has witnessed considerable success in recent years as a treatment for …
Immunotherapy has witnessed considerable success in recent years as a treatment for …
TG468: a text graph convolutional network for predicting clinical response to immune checkpoint inhibitor therapy.
K Wang, J Shi, X Tong, N Qu, X Kong, S Ni… - Briefings in …, 2024 - europepmc.org
Enhancing cancer treatment efficacy remains a significant challenge in human health.
Immunotherapy has witnessed considerable success in recent years as a treatment for …
Immunotherapy has witnessed considerable success in recent years as a treatment for …
[HTML][HTML] TG468: a text graph convolutional network for predicting clinical response to immune checkpoint inhibitor therapy
K Wang, J Shi, X Tong, N Qu, X Kong, S Ni… - Briefings in …, 2024 - ncbi.nlm.nih.gov
Enhancing cancer treatment efficacy remains a significant challenge in human health.
Immunotherapy has witnessed considerable success in recent years as a treatment for …
Immunotherapy has witnessed considerable success in recent years as a treatment for …
TG468: a text graph convolutional network for predicting clinical response to immune checkpoint inhibitor therapy.
K Wang, J Shi, X Tong, N Qu, X Kong, S Ni… - Briefings in …, 2024 - europepmc.org
Enhancing cancer treatment efficacy remains a significant challenge in human health.
Immunotherapy has witnessed considerable success in recent years as a treatment for …
Immunotherapy has witnessed considerable success in recent years as a treatment for …